AOA Dx

AOA

This company develops non-invasive liquid biopsy blood tests for the early detection of ovarian cancer for healthcare providers and patients.

AOA Diagnostics

This biotech company develops AI-enabled liquid biopsy blood tests to detect early-stage ovarian cancer in symptomatic women.

Fyr Bio

This company develops liquid biopsy diagnostic tools and biomarkers using extracellular vesicle enrichment technology for healthcare providers and pharmaceutical researchers.

Voc Diagnostics

This company develops diagnostic instruments using machine learning and sensor technology to detect ovarian cancer from blood plasma samples for healthcare providers.

AnchorDx

This company develops non-invasive liquid biopsy tests and diagnostic tools for early cancer screening, diagnosis and recurrence monitoring for healthcare providers and patients.

PETDX

This company develops liquid biopsy blood tests for the early detection of cancer in dogs for use by veterinary professionals.

Hedera Dx

This company develops blood-based liquid biopsy tests and software for hospital laboratories to perform in-house molecular cancer diagnostics for patients.

LiquidCell Dx

This company develops blood-based liquid biopsy tests for tumor microenvironment profiling to help pharmaceutical companies and clinical partners predict cancer therapy responses.